| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 11.32B | 10.12B | 12.46B | 13.01B | 17.59B | 18.38B |
| Gross Profit | 3.59B | 3.31B | 3.89B | 3.50B | 5.47B | 7.32B |
| EBITDA | 209.25M | -518.00M | 507.00M | -1.33B | 574.00M | 1.81B |
| Net Income | -361.00M | -1.60B | 67.00M | -2.07B | 3.00M | 1.01B |
Balance Sheet | ||||||
| Total Assets | 5.54B | 4.66B | 6.18B | 7.80B | 9.91B | 10.88B |
| Cash, Cash Equivalents and Short-Term Investments | 1.30B | 673.00M | 1.34B | 1.17B | 1.25B | 1.00B |
| Total Debt | 449.00M | 769.00M | 428.00M | 1.44B | 1.41B | 1.42B |
| Total Liabilities | 1.54B | 1.85B | 1.83B | 3.54B | 3.60B | 4.59B |
| Stockholders Equity | 4.00B | 2.81B | 4.35B | 4.26B | 6.31B | 6.29B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -890.00M | 1.16B | -192.00M | 231.00M | -4.12B |
| Operating Cash Flow | 0.00 | -577.00M | 1.35B | 246.00M | 840.00M | -3.24B |
| Investing Cash Flow | 0.00 | -429.00M | -205.00M | -371.00M | -621.00M | -964.00M |
| Financing Cash Flow | 0.00 | 341.00M | -1.01B | 44.00M | 5.00M | 738.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
82 Outperform | ¥16.93B | 10.18 | ― | 2.30% | 9.86% | 119.10% | |
80 Outperform | ¥4.21B | 8.05 | ― | 1.44% | 0.65% | -39.91% | |
76 Outperform | ¥5.91B | 8.45 | ― | 1.76% | 7.17% | 214.23% | |
75 Outperform | ¥8.84B | 22.51 | ― | 4.49% | -9.68% | -61.01% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
50 Neutral | ¥4.48B | -12.30 | ― | 3.25% | -1.20% | -1136.47% | |
45 Neutral | ¥5.46B | -3.41 | ― | ― | -23.54% | -14.54% |
BALMUDA Inc. reported a sharp deterioration in performance for the fiscal year ended December 31, 2025, with net sales falling 18.8% year on year to ¥10.1 billion and a swing to an operating loss of ¥866 million and a net loss of ¥1.6 billion. The company’s equity ratio declined to 60.3% from 70.4% as total assets shrank, while cash and cash equivalents nearly halved, reflecting negative operating and investing cash flows partly offset by financing inflows.
The board maintained its conservative stance on shareholder returns, paying no dividends for 2025 and forecasting none for 2026 as it prioritizes rebuilding profitability and capital strength. For the 2026 fiscal year, management projects a modest 3.8% rebound in net sales to ¥10.5 billion and a return to a small profit, signaling a cautious recovery path that will be closely watched by investors assessing the company’s ability to stabilize its operations and restore growth.
The most recent analyst rating on (JP:6612) stock is a Hold with a Yen632.00 price target. To see the full list of analyst forecasts on BALMUDA, Inc. stock, see the JP:6612 Stock Forecast page.